{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:13:38Z","timestamp":1784312018297,"version":"3.55.0"},"publisher-location":"Berlin, Heidelberg","reference-count":33,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642626760","type":"print"},{"value":"9783642563522","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002]]},"DOI":"10.1007\/978-3-642-56352-2_9","type":"book-chapter","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T20:34:50Z","timestamp":1304541290000},"page":"67-80","source":"Crossref","is-referenced-by-count":20,"title":["Identification of Prognostic Factors in Post-Transplant Lymphoproliferative Disorders"],"prefix":"10.1007","author":[{"given":"Sylvain","family":"Choquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France Mamzer","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Nguyen","family":"Quoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Charlotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dorent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Barrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Vernant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","volume":"342","author":"G Opelz","year":"1993","unstructured":"Opelz G, Henderson R, for the Collaborative Transplant Study (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514\u20131516","journal-title":"Lancet"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.1995.13.4.961","volume":"13","author":"V Leblond","year":"1995","unstructured":"Leblond V, Sutton L, Dorent R et al. (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases in a single center. J Clin Oncol 13:961\u2013968","journal-title":"J Clin Oncol"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJM199012203232510","volume":"323","author":"I Penn","year":"1990","unstructured":"Penn I (1990) Cancers complicating organ transplantation. N Engl J Med 323: 1767\u20131769","journal-title":"N Engl J Med"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.1998.16.1.1","volume":"16","author":"V Leblond","year":"1998","unstructured":"Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, Gandjbakhch I, Binet JL, Raphael M (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16:1\u20139","journal-title":"J Clin Oncol"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ajcp\/92.2.177","volume":"92","author":"PS Randhawa","year":"1989","unstructured":"Randhawa PS, Yousem SA, Paradis IL el. al (1989) The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 92:177\u2013185","journal-title":"Am J Clin Pathol"},{"key":"9_CR6","first-page":"877","volume":"10","author":"JM Armitage","year":"1991","unstructured":"Armitage JM, Kormos RL, Stuart RS et al. (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877\u2013887","journal-title":"J Heart Lung Transplant"},{"key":"9_CR7","first-page":"173","volume":"133","author":"MA Nalesnik","year":"1988","unstructured":"Nalesnik MA, Jaffe R, Starzl TE et al (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine Aprednisone immunosuppression. Am J Pathol 133:173\u2013192","journal-title":"Am J Pathol"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00007890-198505000-00001","volume":"39","author":"DW Hanto","year":"1985","unstructured":"Hanto DW, Frizzera G, Galj-Peczalska et aL (1985) Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation. Transplantation 39:461\u2013472","journal-title":"Transplantation"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","volume":"85","author":"DM Knowles","year":"1995","unstructured":"Knowles DM, Cesarman E, Chadburn A et al. (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552\u2013565","journal-title":"Blood"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The international non-Hodgkins lymphoma prognostic factors project","year":"1993","unstructured":"The international non-Hodgkin\u2019s lymphoma prognostic factors project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329:987\u2013994","journal-title":"N Engl J Med"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V83.5.1165.1165","volume":"83","author":"M Shipp","year":"1994","unstructured":"Shipp MA (1994) Prognostic factors in aggressive non-Hodgkin lymphoma: who has \u201chigh-risk\u201d disease? Blood 83:1165\u20131173","journal-title":"Blood"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJM199105233242102","volume":"324","author":"A Fischer","year":"1991","unstructured":"Fischer A, Blanche S, Le Bidois J et al. (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451\u20131456","journal-title":"N Engl J Med"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00007890-199208000-00011","volume":"54","author":"JL Stephan","year":"1992","unstructured":"Stephan JL, Le Deist F, Blanche S et al. (1992) Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody. Transplantation 54:246\u2013249","journal-title":"Transplantation"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.152.11.5361","volume":"52","author":"A Durandy","year":"1994","unstructured":"Durandy A, Emilie D, Peuchmaur M et al. (1994) Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. J Immunol 52:5361\u20135367","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"9_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/annonc\/11.suppl_1.S113","volume":"11","author":"N Milpied","year":"2000","unstructured":"Milpied N, Vasseur B, Parquet N et al. (2000) Humanized anti-CD20 monoclonal antibody (rituximab) in B posttransplant lymphoproliferative disorders: a retrospective analysis on 32 patients. Ann Oncol 11 (Suppl 1): S 113\u2013116","journal-title":"Ann Oncol"},{"key":"9_CR16","first-page":"8","volume":"14","author":"NL Harris","year":"1997","unstructured":"Harris NL, Ferry JA, Swerdelow SH (1997) Posttransplant lymphoproliferative disorders: summary of Society for Hemathopathology Workshop. Semin Diagn Pathol 14:8\u201314","journal-title":"Semin Diagn Pathol"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H (1981) Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled (PAP) procedures. J Histochem Cytochem 29:577\u2013580","journal-title":"J Histochem Cytochem"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/32.2.6198355","volume":"32","author":"JL Cordell","year":"1984","unstructured":"Cordell JL, Falini B, Erber WN (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphate anti alkaline phosphatase (APAAP complex). J Histochem Cytochem 32:219\u2013229","journal-title":"J Histochem Cytochem"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1006\/mcpr.1993.1014","volume":"7","author":"JM Barletta","year":"1993","unstructured":"Barletta JM, Kingma DW, Ling Y et al (1993) Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes 7:105\u2013109","journal-title":"Mol Cell Probes"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"54","author":"AL Kaplan","year":"1958","unstructured":"Kaplan AL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 54:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"74","author":"D Cox","year":"1972","unstructured":"Cox DR (1972) Regression model and Mfe tables. J R Stat Soc B 74:187\u2013220","journal-title":"J R Stat Soc B"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residual. Biometrika 81:515\u2013526","journal-title":"Biometrika"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1182\/blood.V92.9.3137","volume":"92","author":"M Benkerrou","year":"1998","unstructured":"Benkerrou M, Jais JP, Leblond V et al. (1998) Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood 92:3137\u20133147","journal-title":"Blood"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-199501000-00016","volume":"59","author":"I Penn","year":"1995","unstructured":"Penn I, Porat G (1995) Central nervous system in organ allograft recipients. Transplantation 59:240\u2013244","journal-title":"Transplantation"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood.V82.1.247.bloodjournal821247","volume":"82","author":"EK Waller","year":"1993","unstructured":"Waller EK, Ziemianska M, Bangs CD et al. (1993) Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice. Blood 82:247\u2013261","journal-title":"Blood"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1182\/blood.V88.9.3626.bloodjournal8893626","volume":"88","author":"MN Hanson","year":"1996","unstructured":"Hanson MN, Morrison VA, Peterson BA et al. (1996) Posttransplant T-cell lymphoproliferative disorders: an aggressive, late complication of solid-organ transplantation. Blood 88:3626\u20133633","journal-title":"Blood"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(94)90043-4","volume":"97","author":"VA Morrison","year":"1997","unstructured":"Morrison VA, Dunn DL, Manivel JC, Gfil-Peczalska KL Peterson BA (1997) Clinical characteristics of posttransplant lymphoproliferative disorders. Am J Med 97:14\u201324","journal-title":"Am J Med"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood.V86.9.3333.bloodjournal8693333","volume":"86","author":"LJ Swinnen","year":"1995","unstructured":"Swinnen LJ Mullen GM, Carr TJ, Costanzo MR, Fisher RI (1995) Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 86:3333\u20133340","journal-title":"Blood"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/1097-0142(19931101)72:9<2782::AID-CNCR2820720941>3.0.CO;2-H","volume":"72","author":"TL Garett","year":"1993","unstructured":"Garett TL Chadburn A, Barr ML et al. (1993) Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristineprednisone chemotherapy. Cancer 72:2782","journal-title":"Cancer"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V88.1.242.242","volume":"88","author":"DW Kingma","year":"1996","unstructured":"Kingma DW, Weiss WB, Jaffe ES et al. (1996) Epstein-Barr virus latent membrane protein-1 oncogene deletions correlations with malignancy in Epstein-Barr associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242","journal-title":"Blood"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.V87.2.706.bloodjournal872706","volume":"87","author":"PG Murray","year":"1996","unstructured":"Murray PG, Swinnen LJ, Constandinou CM et al. (1996) Bcl-2 but not its Epstein-Barr virus-encoded homologue BHRFl, is commonly expressed in post-transplantation lymphoproliferative disorders. Blood 87:706","journal-title":"Blood"},{"issue":"Suppl 1","key":"9_CR32","first-page":"2295","volume":"94","author":"SM Horwitz","year":"1999","unstructured":"Horwitz SM, Ranheim EA, Morgan DS, Horning SJ (1999) A unified approach to posttransplant lymphoproliferative disorder (PTLD): improved outcome and analysis of prognostic factors (abstract). Blood 94 (Suppl 1):2295","journal-title":"Blood"},{"key":"9_CR33","first-page":"2296","volume":"94 Suppl 1","author":"TM Habermann","year":"1999","unstructured":"Habermann TM, Ansell SM, Velosa JA et al. (1999) Posttransplant lymphoproliferative disorders (PTLD): long-term outcome and prognostic factors (abstract). Blood 94 (Suppl 1):2296","journal-title":"Blood"}],"container-title":["Recent Results in Cancer Research","Immunosurveillance, Immunodeficiencies and Lymphoproliferations"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-56352-2_9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:14:04Z","timestamp":1741173244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-56352-2_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"ISBN":["9783642626760","9783642563522"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-56352-2_9","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}